Dr. Ashley Parham Ghiaseddin, MD

Dr. Ghiaseddin practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Ghiaseddin's NPI, 1952622045, was assigned on June 12, 2010. Dr. Ghiaseddin graduated from University of Toledo College of Medicine and Life Sciences in 2010. Dr. Ghiaseddin holds Florida license ME123777.

Dr. Ghiaseddin's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Ghiaseddin's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghiaseddin practices. Vendor and product names are available with a free account.

Neurology is Dr. Ghiaseddin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ghiaseddin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Ghiaseddin's licenses on file in 3 states: Florida, Indiana and North Carolina.

Dmand AI lists breast cancer among the conditions Dr. Ghiaseddin treats.

CMS data shows 380 Medicare services from Dr. Ghiaseddin across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $26,948 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Ghiaseddin in 2024. The largest group is 65 to 74, with 39 patients. 62% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ghiaseddin's median patient age at 66, with 46% women.

In 2024, Dr. Ghiaseddin wrote 111 Medicare Part D claims for 28 patients. 58% of them were for generic drugs. CMS names the drug for 57 of them, across 5 drugs with 11 or more claims each, at $114,529 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Ghiaseddin for performance year 2024, reported through an alternative payment model (APM). Dr. Ghiaseddin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghiaseddin as offering telehealth.

Dmand AI links 21 papers to Dr. Ghiaseddin, published from 2017 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Craniotomy and Algorithms. Dr. Ghiaseddin has published most often in Neurooncol Adv. Dr. Ghiaseddin's most frequent co-authors are Maryam Rahman, MD, Sandra C. Yan, MD and Katherine Barnett Peters, MD, PhD.

Dmand AI links Dr. Ghiaseddin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Lymphoma, Follicular and Glioblastoma.

CMS Open Payments shows 53 general payments to Dr. Ghiaseddin from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 70% of the total. Novocure Inc. paid the most, $12,528.

Dr. Ghiaseddin graduated from University of Toledo College of Medicine and Life Sciences in 2010.

Dr. Ghiaseddin is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.